Canopus Biopharma (CBIA) is showing potential for a bullish trajectory over the next 1-2 weeks, contingent on upcoming updates. The first target lies at the confluence area of the first trend line and Fibonacci ratio resistance around .0006. If this level is breached, the next target is at .0010.
Above these levels, I'll set my personal sell limit on 75% of my...
